HeartMate 3 LVAD

With Full Maglev Flow Technology

About HeartMate 3 LVAD with Full MagLev Flow Technology

The HeartMate 3™ LVAD with Full MagLev™ Flow Technology has significantly advanced the field of LVAD therapy, setting the standard with innovation and outstanding clinical outcomes that make a meaningful difference in your patients’ lives.1

This innovation includes Full MagLev Flow Technology, which maintains gentle blood handling to minimize complications and hemocompatibility-related adverse events.1

The HeartMate 3 LVAD is used for advanced heart failure patients needing short- or long-term mechanical circulatory support.

Outcomes made possible by Full MagLev Flow Technology

Full MagLev Flow Technology maintains gentle blood handling to minimize complications and hemocompatibility-related adverse events.

  • Fully levitated, self-centering rotor that does not require hydrodynamic or mechanical bearings
  • Large, consistent blood flow pathways to reduce shear stress3
  • Intrinsic pulsatility to reduce stasis and minimize thrombus3,4
Cut across view of the HeartMate 3 Maglev Pump
Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.

References

  1. Mehra M, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
  2. Abbott data on file.
  3. Bourque K, Cotter C, Dague C, et al. Design rationale and preclinical evaluation of the HeartMate 3 Left Ventricular Assist System for hemocompatibility. Am Soc Artificial Int Organs. 2016;62:375- 383.
  4. Bourque K, Dague C, Farrar D, et al. In vivo assessment of a rotary left ventricular assist deviceinduced artificial pulse in the proximal and distal aorta. Artificial Organs. 2006;30:638-642.

MAT-2105166 v2.0